Stryker Corporation (SYK) was Upgraded by Sterne Agee CRT to ” Buy”. Earlier the firm had a rating of “Neutral ” on the company shares. Sterne Agee CRT advised their investors in a research report released on Apr 27, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .Barclays Resumed Stryker Corporation on Apr 11, 2016 to “Underweight”, Price Target of the shares are set at $107.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Stryker Corporation opened for trading at $109.44 and hit $110.06 on the upside on Friday, eventually ending the session at $109.4, with a gain of 0.08% or 0.09 points. The heightened volatility saw the trading volume jump to 18,37,756 shares. Company has a market cap of $40,804 M.
In a different news, on Apr 26, 2016, Louise Francesconi (director) sold 4,985 shares at $108.93 per share price. According to the SEC, on Apr 25, 2016, William E Jr Berry (VP, Corporate Controller) sold 3,339 shares at $109.23 per share price. On Apr 25, 2016, Ronda E Stryker (director) sold 12,000 shares at $108.69 per share price, according to the Form-4 filing with the securities and exchange commission.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.